US Patent Issued to Emory University on Jan. 20 for "Platinum-based chemotherapy, mast binding agents, glucocorticoid receptor (GR) binding agents, and/or HSP90 binding agents for uses in treating cancer" (Georgia Inventors)

ALEXANDRIA, Va., Jan. 20 -- United States Patent no. 12,527,818, issued on Jan. 20, was assigned to Emory University (Atlanta).

"Platinum-based chemotherapy, mast binding agents, glucocorticoid receptor (GR) binding agents, and/or HSP90 binding agents for uses in treating cancer" was invented by Sumin Kang (Atlanta) and Jing Chen (Atlanta).

According to the abstract* released by the U.S. Patent & Trademark Office: "This disclosure relates to methods of treating cancer comprising administering an effective amount of a platinum-based chemotherapy agent in combination with a microtubule associated serine/threonine-protein kinase (MAST) inhibitor and/or a glucocorticoid receptor binding agent and/or a hsp90 binding agent and/or other chemothe...